During the past decades anal cancer incidence has increased in line with the HIV epidemic. The rate of anal cancer in HIV-positive MSM is currently 35 per 100,000 which is approaching the same level as cervical cancer in women.1

Prevent anal cancer with HPV testing

Human papillomavirus (HPV) infection has been implicated as the prerequisite for the development of the majority of anogenital malignancies accounting for more than 90% of the cervical and anal cancers.2 These observations support the need to implement screening to prevent anal cancer.


Publications:

  1. Palefsky JM, et al. 2001. J.Inf. Dis. 183:383-391
  2. Walboomers JM, et al. J.Pathol. 1999, 189: 12-19